BioPartnering North America

BioPartnering North America

December 01, 2008 03:00 ET

Register for BioPartnering North America (BPN) Now and Save CAD $450 Off the General Registration Rate

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 1, 2008) - Technology Vision Group LLC (TVG) is pleased to announce the availability of the early registration rate for the 7th Annual BioPartnering North America (BPN) conference, to be held in Vancouver, B.C., Canada, on February 8-10, 2009.

Register for BPN now at and save CAD $450 off the general registration rate.

Pharmaceutical companies may also be eligible to receive two registrations for the price of one! Certain restrictions apply. Contact for details.

Other special registration rates also available for government and academic affiliations, visit for more details.

Hosted by leading life science associations LifeSciences British Columbia, BIOTECanada, and BioAlberta, BPN continues to be one of the most dynamic life science conferences in North America by offering unique opportunities to meet, partner and network with leading pharmaceutical, biotechnology, financial, and service companies from around the world. Last year's conference featured 100 company presentations, with over 900 attendees from nearly 500 international life science companies and organizations.

Company Presentations

BPN offers two presentation formats focused on business development and forming partnerships. To see a list of companies attending BPN 2009, visit

This year, BPN will showcase ninety-four innovative companies from all parts of the world in 13-minute podium presentations. Company presentations provide excellent exposure for companies to a broad spectrum of international life science business development executives from the biotech, pharmaceutical, investor, government and academic communities. In the past BPN podium presentations have featured many young companies that have gone on to become some of the industry's most important players.

Presenting opportunities will be limited to 114 companies and with places filling up fast apply online now to secure your presentation slot at:

Open House Presentations

A hallmark of BPN, the Open House format will feature 20 companies offering interactive presentations in specially constructed booths in Salon D, which is located directly across from the registration desk on the main floor. This year's Open House features leading biotech companies and representatives from biotech clusters around the world. Open House presenters will be available during a two-hour period for interactive presentations and informal discussions with business development executives to promote their innovative technologies and partnering goals. Open House presenters will also have the opportunity to use their semi-private booths for five hours to schedule one-on-one partnering meetings with interested attendees.

Full Program of Sessions, Workshops, and Networking Opportunities

A full program of BioPartnering Leadership Sessions, Sponsor Workshops, and outstanding networking opportunities with senior executives from the life sciences takes place at BPN, creating an environment of business development activities that is focused on partnering.

The Power of Meeting Scheduler Opens December 1st!

BPN attendees will have access to, the leading life science conference partnering tool. lets attendees pre-schedule meetings in advance of the event, prospect attendees, and use effective time-management tools to create the optimal conference experience and make the best use of time onsite. Presenting companies may also submit a short video to that can be viewed in a dedicated area by all attendees, letting presenting companies promote themselves in advance of the event in a dynamic and engaging manner. BPN 2008 attendees enjoyed a 40% increase in the number of meetings scheduled.

"I believe that is one of the best systems out there for efficiency and ease in setting up private meetings," commented Ms. Pamela Demain, Executive Director, Corporate Licensing, Merck & Co., Inc.

Canadian Bursary

Technology Vision Group LLC is strongly committed to the Canadian biotechnology industry, and together with BIOTECanada, has financed scholarships to allow students from across Canada to attend BioPartnering North America (BPN). For details on deadlines and how to apply, please contact Graeme Fraser, BIOTECanada at +1.613.230.5585 x233.

Full details about BioPartnering North America online at:


BioAlberta, BIOTECanada, LifeSciences British Columbia

LifeSciences British Columbia supports and represents the biotechnology, medical device, and greater life sciences community of British Columbia through leadership, advocacy and promotion. BIOTECanada is the national, industry-funded association representing the broad spectrum of biotech constituents in Canada, including emerging, established and related service companies in the health, agricultural, and industrial sectors. BioAlberta is the central voice and the organizing hub for the bioindustry in Alberta. Together, they represent the breadth of annual support for BPN from Canadian life science associations on the regional and national level.

Premium Sponsors


Gold Sponsors

Burrill & Company; Farris, Vaughn, Willis & Murphy Barristers and Solicitors; Pfizer; Ferghana Partners Group

Silver Sponsors

Bristol-Myers Squibb; Merck & Co., Inc.; Merck Frosst; Procter & Gamble Health Care; Anapharm; Roche; Crucell; Novartis; State of Illinois Canada Office

Conference Sponsors

Genome British Columbia

Conference Supporters

BIA, Citigate Dewe Rogerson, Marketwire, and Washington Biotechnology & Biomedical Association (WBBA)

Media Supporters

FierceBiotech, BioBusiness, BioCentury, Biotechnology Focus, Nature Publishing Group, European Biopharmaceutical Review, Progress Research and Discovery Magazine.

2009 Open House Presenters

Apthera, Inc.; Alphora Research Inc.; Ambassade de France Mission economique; Ambit Biosciences; Bend Research; CIRION Clinical Trial Services Inc.; Crucell N.V.; ImmunoVaccine Technologies Inc.; Inimex Pharmaceuticals, Inc.; Italian Trade Commission; Pharmaceutical Profiles Ltd.; Pharmatek Laboratories, Inc.; Piramal Healthcare; Prince Edward Island Business Development; QSV Biologics Ltd.; Silence Therapeutics AG; UK Trade & Investment

2009 Podium Presenters

Apthera, Inc.; Affibody AB; Agile Therapeutics, Inc.; AIM Therapeutics Inc.; Akesis Pharmaceuticals, Inc.; Alpharma Inc.; Apeiron Biologics; Apoplogic Pharmaceuticals, LLC; Aquinox Pharmaceuticals Inc.; Asterand plc; Bend Research; Biolex Therapeutics; Bionor Immuno AS; Bionovo; BioWisdom Ltd; Calibrant Biosystems, Inc; Ceapro Inc.; Cellzome AG; Centre for Drug Research and Development; CoMentis, Inc.; Critical Pharmaceuticals Ltd; Curis, Inc; Cynvec; Cytovance Biologics; Diosynth Biotechnology, Inc; Endotis Pharma; Eurand International S.p.A.; Innate Pharma; Inovio Biomedical Corp.; Jerini AG; KAI Pharmaceuticals Inc.; Meditrina Pharmaceuticals, Inc.; metanomics Health GmbH; MiCardia; Micromet AG; Migco Pharmaceuticals Ltd.; Modigene Inc.; Nektar Therapeutics; NeoMPS; Nerites Corporation; Novacta Biosystems Limited; Numerate, Inc.; Office of Biomedical Advanced Research and Development Authority (BARDA); Oncogenex Pharmaceuticals, Inc.; Oncolytics Biotech Inc.; Protalix Biotherapeutics Ltd; Protein Forest, Inc.; Proteos, Inc.; PRUDENTAS LLC; Rules-Based Medicine, Inc.; Sandoz International GmbH; Selvita sp. z o.o.; SemBioSys Genetics; Signum Biosciences Inc.; Sirona Biochem; Speciality European Pharma Limited; Stem Cell Therapeutics; Stromedix, Inc.; Summit plc; SuppreMol GmbH; TAU Therapeutics; Transcept Pharmaceuticals; Vakzine Projekt Management GmbH; Victory Pharma; VLST Corp; Welichem Biotech Inc.; Xenome Limited; YM BioSciences Inc.; Zymeworks

Contact Information